Sign in
4

Changes in Ownership

Dare Bioscience, Inc. Filed Acc 0001209191-17-002068

Chief Executive Officer acquired 5,733 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GUIFFRE CHRISTOPHERD T Chief Executive Officer 2016-12-31 Grant or award +5,733 $0.60 $3,440 12,489 D: show line 1 in the form
Loading xslF345X03/doc4.xml…